5-[4-(4-Oxo-piperidin-1-yl)-benzyl]-thiazolidine-2,4-dione → 5-{4-[4-((2R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-piperidin-1-yl]-benzyl}-thiazolidine-2,4-dione

HRID 1061284Notes

Reaction equation

HRID 1061284 reaction equation
[NH2:1][CH2:2][C@@H:3]([C:5]1[CH:6]=[N:7][CH:8]=[CH:9][CH:10]=1)[OH:4].O=[C:12]1[CH2:17][CH2:16][N:15]([C:18]2[CH:31]=[CH:30][C:21]([CH2:22][CH:23]3[S:27][C:26](=[O:28])[NH:25][C:24]3=[O:29])=[CH:20][CH:19]=2)[CH2:14][CH2:13]1>>[OH:4][C@H:3]([C:5]1[CH:6]=[N:7][CH:8]=[CH:9][CH:10]=1)[CH2:2][NH:1][CH:12]1[CH2:13][CH2:14][N:15]([C:18]2[CH:31]=[CH:30][C:21]([CH2:22][CH:23]3[S:27][C:26](=[O:28])[NH:25][C:24]3=[O:29])=[CH:20][CH:19]=2)[CH2:16][CH2:17]1

Participants

3

Procedure

The title compound was prepared from (1R)-2-amino-1-(3-pyridinyl)-1-ethanol (which was obtained in Example 135) and 5-[4-(4-oxo-1-piperidineyl)benzyl]-1,3-thiazolidine-2,4-dione (which was obtained in Example 38) in substantially the same manner, as described in Example 125. The product was obtained as a yellow solid; mp 87° C. (decomposed); 1H NMR (400 MHz, DMSO-d6) δ 1.38-1.43 (m, 2H), 1.89-1.91 (m, 2H), 2.62-2.71 (t, 2H), 2.71-2.91 (m, 4H), 3.23-3.27 (m, 1H), 3.60-3.63 (m, 2H), 4.58-4.61 (m, 1H), 4.72-4.75 (m, 1H), 6.83-6.85 (d, 2H), 7.02-7.05 (d, 2H), 7.34-7.37 (m, 1H), 7.75-7.78 (m, 1H), 8.45-8.46 (m, 1H), 8.56-8.57 (m, 1H); MS (ES) m/z: 427 (MH+).

Workup

  1. customThe product was obtained as a yellow solid

Sources & evidence

ORD record
ord-d4f050a41b5b47ca84e20b0194f223a3
Source dataset
uspto-grants-2003_02
Patent number
US06525202B2

Reaction notes

Loading…